Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 143 No. 0708 (2013)

Frequency and severity of pain and symptom distress among patients with chronic kidney disease receiving dialysis

  • Claudia Gamondi
  • Nadia Galli
  • Carlo Schönholzer
  • Claudio Marone
  • Hugo Zwahlen
  • Luca Gabutti
  • Giorgia Bianchi
  • Claudia Ferrier
  • Claudio Cereghetti
  • Olivier Giannini
DOI
https://doi.org/10.4414/smw.2013.13750
Cite this as:
Swiss Med Wkly. 2013;143:w13750
Published
10.02.2013

Summary

QUESTION UNDER STUDY: Data on pain management in haemodialysis patients with end-stage renal disease are scanty. Our study aimed to collect information on the frequency and severity of pain and symptom distress among long-term dialysis patients in southern Switzerland.

METHODS: Patients with chronic kidney disease stage 5, on dialysis, treated in five nephrology units in southern Switzerland, who had given informed consent and were able to complete the survey, were interviewed to assess pain and correlated symptoms using a Visual Analogue Scale (VAS), the Brief Pain Inventory and the Edmonton Symptom Assessment System. To evaluate the impact of symptoms, the Instrumental Activities of Daily Living questionnaire was used.

RESULTS: One hundred and twenty-three patients, aged 36–90 years and with a mean time on dialysis of 3.5 years, were interviewed. Pain was experienced by 81 patients during the 4 weeks before the interview: 68 had chronic pain; 66 reported pain intensity higher than 5 on the VAS; 35 identified musculoskeletal pain as the most disturbing pain. Five patients used drugs to cope with pain during the night. Asthenia and fatigue were prevalent concomitant symptoms. Asthenia, fatigue, sleep disturbances, dyspnoea, loss of appetite, nausea/vomiting and anxiety were correlated with pain. The majority of the patients reported that their pain limited their daily life activities.

CONCLUSIONS: Pain severity and symptom distress in dialysis patients are important, but underestimated and undertreated. They interfere with sleep quality and daily living. Routine assessment of pain burden, pain management similar to that used in palliative care, and adequate analgesic use to treat specific dialysis-associated pain syndromes should be considered in guidelines.

References

  1. Merskey H, Bogduk N. Classification of chronic pain. Seattle, WA: International Association for the Study of Pain Press; 1994. 240 p.
  2. Murtagh FE, Addington-Hall JM, Edmonds PM, Donohoe P, Carey I, Jenkins K, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007;10(6):1266–76. PubMed PMID: 18095805. Epub 2007/12/22.
  3. Murphy EL, Murtagh FE, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):c74–80. PubMed PMID: 19088482. Epub 2008/12/18.
  4. Bouattar T, Skalli Z, Rhou H, Ezzaitouni F, Ouzeddoun N, Bayahia R, et al. [The evaluation and analysis of chronic pain in chronic hemodialysis patients.] Nephrol Ther. 2009;5(7):637–41. PubMed PMID: 19625232. Epub 2009/07/25French.
  5. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42(6):1239–47. PubMed PMID: 14655196. Epub 2003/12/05.
  6. Ferro C, Chambers J, Davison S. Management of pain in renal failure. In: Chambers JE GM, Brown E editor. Supportive care for the renal patient: Oxford University Press; 2005. p. 105–53.
  7. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in chronic kidney disease. 2007;14(1):82–99. PubMed PMID: 17200048. Epub 2007/01/04.
  8. Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int. 2004;65(6):2419–25. PubMed PMID: 15149355. Epub 2004/05/20.
  9. Claxton RN, Blackhall L, Weisbord SD, Holley JL. Undertreatment of symptoms in patients on maintenance hemodialysis. J Pain Symptom Manage. 2010;39(2):211–8. PubMed PMID: 19963337. Epub 2009/12/08.
  10. Fortina F, Agliata S, Regazzoni E, Sacco A, Cardillo V, Ravaglini S, et al. Chronic pain during dialysis: Pharmacologic therapy and its costs. Minerva Urol Nefrol. 1999;51:85–7.
  11. Meyer KB, Espindle DM, DeGiacomo JM, Jenuleson CS, Kurtin PS, Davies AR. Monitoring dialysis patients’ health status. Am J Kidney Dis. 1994;24(2):267–79. PubMed PMID: 8048434. Epub 1994/08/01.
  12. King S, Forbes K, Hanks GW, Ferro CJ, Chambers EJ. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011;25(5):525–52. PubMed PMID: 21708859. Epub 2011/06/29.
  13. Andreucci VE, Fissell RB, Bragg-Gresham JL, Ethier J, Greenwood R, Pauly M, et al. Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients. Am J Kidney Dis. 2004;44(5 Suppl 2):61–7. PubMed PMID: 15486876. Epub 2004/10/16.
  14. Barakzoy AS, Moss AH. Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease. J Am Soc Nephrol. 2006;17(11):3198–203. PubMed PMID: 16988057. Epub 2006/09/22.
  15. Saini T, Murtagh FE, Dupont PJ, McKinnon PM, Hatfield P, Saunders Y. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat Med. 2006;20(6):631–6. PubMed PMID: 17060257. Epub 2006/10/25.
  16. Weisbord SD, Carmody SS, Bruns FJ, Rotondi AJ, Cohen LM, Zeidel ML, et al. Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients. Nephrol Dial Transplant. 2003;18(7):1345–52. PubMed PMID: 12808172. Epub 2003/06/17.
  17. Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007;2(5):960–7. PubMed PMID: 17702730. Epub 2007/08/19.
  18. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47. PubMed PMID: 12859163. Epub 2003/07/16.
  19. Cleeland C. Research in cancer pain. What we know and what we need to know. Cancer. 1991;67(3 Suppl):823–7. PubMed PMID: 1986852. Epub 1991/02/01.
  20. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6–9. PubMed PMID: 1714502. Epub 1991/01/01.
  21. Bruera E, MacMillan K, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: preliminary report. Pain. 1989;37(2):203–9. PubMed PMID: 2748193. Epub 1989/05/01.
  22. Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L, et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage. 2002;23(3):239–55. PubMed PMID: 11888722. Epub 2002/03/13.
  23. Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant. 2006;21(11):3189–95. PubMed PMID: 16957010. Epub 2006/09/08.
  24. Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F. A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage. 2011;41(2):456–68. PubMed PMID: 20832987. Epub 2010/09/14.
  25. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63(1):65–76. PubMed PMID: 8577492. Epub 1995/10/01.
  26. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86. PubMed PMID: 5349366. Epub 1969/01/01.
  27. Poux J, Lagarde C, Peyronez P, Boudet R, Gontier Y, Benevent D. La douleur en hémodialyse: résultats d’une enquête prospective chez 172 patients utilisant un questionnaire multidimension d’autoévaluation. Nephr Ther. 2005;1:S77–S137. French
  28. D’Astolfo CJ, Humphreys BK. A record review of reported musculoskeletal pain in an Ontario long term care facility. BMC Geriatr. 2006;6:5. PubMed PMID: 16556306. Pubmed Central PMCID: 1435899. Epub 2006/03/25.
  29. Gusbeth-Tatomir P, Boisteanu D, Seica A, Buga C, Covic A. Sleep disorders: a systematic review of an emerging major clinical issue in renal patients. Int Urol Nephrol. 2007;39(4):1217–26. PubMed PMID: 17914660. Epub 2007/10/05.
  30. Elder SJ, Pisoni RL, Akizawa T, Fissell R, Andreucci VE, Fukuhara S, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008;23(3):998–1004. PubMed PMID: 17911092. Epub 2007/10/04.
  31. Sanner BM, Tepel M, Esser M, Klewer J, Hoehmann-Riese B, Zidek W, et al. Sleep-related breathing disorders impair quality of life in haemodialysis recipients. Nephrol Dial Transplant. 2002;17(7):1260–5. PubMed PMID: 12105250. Epub 2002/07/10.
  32. Han SY, Yoon JW, Jo SK, Shin JH, Shin C, Lee JB, et al. Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter study. Nephron. 2002;92(1):127–32. PubMed PMID: 12187095. Epub 2002/08/21.
  33. Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005;30(5):465–73. PubMed PMID: 16310620. Epub 2005/11/29.
  34. Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev. 2003;7(2):131–43. PubMed PMID: 12628214. Epub 2003/03/12.
  35. Wyne A, Rai R, Cuerden M, Clark WF, Suri RS. Opioid and benzodiazepine use in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2011;6(2):326–33. PubMed PMID: 21071517. Pubmed Central PMCID: 3052223. Epub 2010/11/13.
  36. Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736–45. PubMed PMID: 22859791. Epub 2012/08/04.

Most read articles by the same author(s)